3rd Annual Manufacturing Execution Systems

Register by May 30, 2008 and Receive $300 Off Your Registration Fee!
3 r d A n n u a l
Manufacturing
Execution Systems
in the Life Sciences Industry
Maximize MES Capabilities within a Lean Organization and
Achieve Enterprise-Wide Integration for Quality and Performance
A U G U S T 5 - 6 , 2 0 0 8 • T H E W E S T I N H O T E L • P H I L A D E L P H I A , P A
16 Industry Perspectives
Michael Asher, Control Engineer, GlaxoSmithKline
Paul Brandenburg, Team Lead,
Site Execution Systems, Eli Lilly & Co
Andreas Dankelmann, Project Manager,
Organization and Information, Bayer HealthCare
Keith T. Evans, Biotech OpU MES Focal Point,
TO&PS BSP, Wyeth Pharmaceuticals
Tony Fenn, Principal Engineer,
Bristol-Myers Squibb
David Gerhart, Manager, Computer System,
Validation & Automation Integration,
Global Technical Services,
Schering Plough Corporation
Andrew Kennedy, Research Biochemical
Engineer, Bioprocess Clinical Manufacturing
and Technology, Merck & Co
Samantha Krebs, Senior Process Improvement
Technical Writer, Shire Pharmaceuticals, Inc.
Tom Litterer, Manager, Boston Scientific
Tracy McMorrow, Manager, Boston Scientific
Rey Medina, Director of Manufacturing Systems,
Cordis, a Johnson & Johnson Company
Jeanette Motzer, Manager, Business Applications,
Genentech
John Oakley, Chief Architect,
Manufacturing Systems, Applied Biosystems
Richard P. Poska, R.Ph., Director,
Global Pharmaceutical Regulatory Affairs,
CMC-GPRD Small Molecule Support, Abbott
Cathal Strain, Senior Director and Team Leader,
API Automation, Pfizer Inc
Lou Verhagen, Associate Director, Manufacturing,
Organon
Case Studies Illustrate How To:
• Apply the ISA-95 approach to manufacturing
• Make dramatic improvements for ‘Right First Time’ metrics for
batch records
• Employ FDA practices and expectations for PAT and Quality by Design
• Achieve seamless and synchronized system architecture with
Manufacturing Control Systems
• Advance in overall quality and performance with MES
• Leverage ISA-88 process mapping for batch record standardization
• Make the move from a home grown legacy system to a
full-functioning MES
• Integrate and interface between ERM, LIMS, SAP and other systems
• Implement mobile technologies for MES
Featuring Two Pre-Conference Workshops — Tuesday, August 5, 2008
A: Unite Manufacturing and Quality Execution —
Achieving a Closed Loop Process
B: Building an EBR System on a Budget
Platinum Sponsor:
Strategic
Corporate
Sponsor:
Organized By:
A Subsidiary of
Executive
Sponsor:
Outstanding Support Provided by:
To Register Call Toll Free
800-817-8601 or
Register on our website
at www.cbinet.com
photo by: John Foxx / Getty Images

2
A
CHOOSE FROM TWO PRE-CONFERENCE WORKSHOPS — TUESDAY, AUGUST 5, 2008
Unite Manufacturing and Quality Execution —
Achieving a Closed Loop Process
Innovators who are first to market are winners, but only if they can also be first to produce high quality products in increasing
volumes. New product introductions are a critical path and require manufacturing to remove obstacles such as variability due to
change and risks of inconsistent quality or even product failure. The new manufacturing and quality model is a platform that
unites Manufacturing Execution with Quality Execution, creating an end-to-end, closed-loop process that is predictive, proactive
and preventive. Combined with actionable intelligence, it provides early warning of process issues that can cause product
problems and root cause analysis that pin points the source of problems and enforcement of changes to prevent recurrence.
Attend this workshop to learn take-home strategies and techniques to implement this essential closed-loop manufacturing and
quality model to speed new product introductions, eliminate root causes of variability and reduce product and compliance risks.
7:30 Workshop Registration
8:30 Workshop Leaders’Welcome and Opening Remarks
I. The Traditional Role of MES
• Understand the investment you are making in MES,
and current industry best practices
• Recognize the disjointed relationship between MES
and Quality Systems, and the inherent limitations
• Review the dramatic increases in CAPAs, complaints
and recalls, and see how gaps in processes lead to them
II. The Manufacturing and Quality
Execution Vision
• Understand the principles of a closed-loop enterprise
manufacturing, quality and intelligence platform,
including the relationship of manufacturing process
and quality information to non-conformances, CAPA
and complaints
• Learn how predictive, proactive, preventive quality is
relevant to enterprise manufacturing
• New and effective ways to:
* enforce and verify manufacturing processes
for more effective change management and
issue prevention
* use pattern recognition for early warning and
visibility into process issues
* improve root-cause analysis to understand actual
cause and scope of non-conformances,
CAPAs and complaints
* ramp up new product introductions by quickly
improving quality
III. The Plan Forward — A Roadmap for
New Product Innovation with High Quality
• Learn the design and architecture of a closed-loop
manufacturing, quality and intelligence platform
• See specific examples of how to better enforce
manufacturing best practices, recognize patterns that
can lead to issues, quickly determine root cause of
problems and proactively prevent recurrences
• See how expanded intelligence can give you
real-time actionable data, pattern recognition,
root cause analysis and quick issue resolution
• Understand the plan and roadmap you can follow
to move from today’s siloed solutions to a
closed-loop manufacturing, quality and intelligence
execution platform
12:00 Close of Workshop A
There will be a 30-minute networking and refreshment break at 10:00 a.m.
— About Your Workshop Leaders —
Julie Fraser is Principal of Industry Directions, an analyst firm that
researches manufacturing and its value network. Ms. Fraser has over
twenty years experience as a manufacturing software advisor and marketer.
Prior to Industry Directions, she was Vice President of Marketing for
Baan Supply Chain Solutions, Senior Analyst at AMR and Editor of CIM
Strategies newsletter.
Karim Lokas is the Vice President of Marketing and Product Strategy at
Camstar where he leads Camstar's Industry Marketing, Marketing
Communications and Product Management teams. His responsibilities
include identifying market and customer needs, driving Camstar's corporate
brand and marketing strategy, managing the Master Product Roadmap for all
of Camstar's target verticals and defining product release requirements.
Mr. Lokas has extensive experience working with global manufacturers in
developing enterprise manufacturing and supply chain strategies and
solutions to drive operational excellence and innovation. A recognized
thought leader and frequent speaker at industry events, Mr. Lokas has been
quoted and published in numerous online and print publications such as MX,
Drug Delivery Technology, Medical Device Link and Managing Automation.
Mr. Lokas holds a Bachelors degree in Electrical Engineering and a Masters
degree focused on Bio-Medical Engineering.
Daniel R. Matlis is the Founder and President of Axendia, a trusted advisor
to Life-Science executives on business, technology and regulatory issues.
Mr. Matlis' eighteen years of experience in the life-sciences industry has
included projects in research and development, manufacturing, regulatory
compliance, business development and information technology. Prior to
founding Axendia, Mr. Matlis was Vice President and General Manager at
Stelex, Inc., a leading consultancy to life-science companies. He started his
professional career at Ethicon, Inc., a Johnson & Johnson Company.
He holds degrees from both Polytechnic University (BS in Electrical
Engineering) and New Jersey Institute of Technology (MS in Management).
Mr. Matlis is the chief contributor and editor of Life-Science Panorama,
a publication covering business, regulatory and technology issues facing
industry executives.

CHOOSE FROM TWO PRE-CONFERENCE WORKSHOPS — TUESDAY, AUGUST 5, 2008
B
Building an EBR System on a Budget
For companies looking to implement an electronic batch record system on a small budget and with limited capabilities, EBR
systems can meet essential company requirements, and be less costly and easier to implement. This workshop walks through the
considerations and capabilities for building an in-house EBR system and also provides a case study of a biologics manufacturer
who built an EBR system from scratch.
7:30 Workshop Registration
8:30 Workshop Leader’s Welcome and Opening Remarks
I. Introduction to Electronic Batch Records
• Limitations with paper batch records
• Considerations for building an EBR system:
* requirements
* construction
* validation
* roll out
II. Comparison of MES and EBR Solutions
• Capabilities:
* interfaces — shop floor automation, MRP system,
LIMS and Operators
• Costs:
* purchase, implementation, maintenance and
business interruption
* total cost of ownership
• Resources needed now/later:
* project management, consulting staff for
customization/validation, technical staff to
maintain
• Time to “Go Live”
III. Considerations for Purchase/Build
• Business requirements
* level of interaction needed with external systems —
schedules, bill of material, recipe management
and LIMS
* web-based considerations
* detail internal/external to batch record
* stability of batch record — do they change often?
* PAT
• Budget, justification and ROI
• Level and type of staffing required:
* internal/external
* short term/long term
• Project duration and business interruption
IV. Case Study of a Biologics Manufacturer
• Design, construction, rollout of an EBR system for a
Biologicals Manufacturer
12:00 Close of Workshop B
There will be a 30-minute networking and refreshment break at 10:00 a.m.
— About Your Workshop Leader —
George Bernstein, Ph.D., has consulted with and held project manager and
director-level positions with major pharmaceutical companies since 1988.
As a consultant, Dr. Bernstein realized how frustrating data collection and
compliance is for pharmaceutical manufacturing companies that use paper
batch records. From these experiences, he developed the concepts and
managed the development of a proprietary EBR system. This system
was successfully validated and has been in use for over seven years.
Dr. Bernstein has lectured on root cause analysis to industry trade groups,
quality organizations, and at Interphex, and has consulted internationally.
Consulting projects include EBR development, computer system validation,
IQ/OQ/PQ development and execution, quality systems design and
development, SCADA system implementation, business process reengineering
and root cause analysis.
DON’T MISS OUR CO-LOCATED EVENT:
Take advantage of the opportunity to
attend the co-located Enterprise
Bio/Pharmaceutical LIMS Conference
on Monday, August 4th. Hear case studies
from Wyeth, Biogen-Idec and others!!
Visit www.cbinet.com/MES
Enterprise-WideLIMS
for the Bio/Pharmaceutical Industry
Strategies for Implementation, Integration
and Validation of Enterprise-Wide Laboratory
Information Management Systems
AUGUST 4, 2008 • THE WESTIN HOTEL • PHILADELPHIA, PA
3

“This conference provided an excellent forum for networking and for discussing
the key challenges and technologies driving the MES industry today.”
— 2007 Attendee, Michael Asher, MES Lead, GlaxoSmithKline
MAIN CONFERENCE
Day One — Tuesday, August 5, 2008
12:00 Main Conference Registration
1:15 Chairman’s Opening Remarks
Dan Matlis, President, Axendia
Achieve Optimal Production and
Manufacturing Quality
1:30 How Life Science Manufacturers Are Attaining
Operational Excellence
Pharmaceutical, biotech and medical device manufacturers
face substantial pressures. To compete and succeed, the
industry must decrease costs, achieve operational
improvements and all the while ensure robust regulatory
compliance. An efficient manufacturer must collaborate
between the enterprise and plant floor across order
management / batch execution; inventory / material, line /
equipment, and personnel planning; while improving
quality control and assurance for review, approval, and
release. This is made even more challenging with the need
to have manufacture automation and processes that can
operate in a multi-product environment rather than the
traditional one process for one product design. The need to
collapse Levels 2 and 3 of the S95 model is profound. This
session illustrates the shifting dynamics driving this need
and provides insight into the implications on work practices
and applied technology required to deliver this efficiency.
• Industry challenges in operations and compliance
• Implications of a ISA-S95-based approach
• Solutions for collaboration in the plant
• Strategies for increased consistency and
“Right First Time” metrics
• Approaches for integrating across systems and facilities
John Blanchard, Principal Analyst, ARC Advisory Group
2:15 Achieving Quality by Design in Pharmaceutical
Manufacturing — An Update on PAT/QbD
Regulatory Expectations and Submissions
The FDA has challenged the industry to achieve a level of
process understanding that is commensurate with a high
level of control around process variability and product
quality in “real time”. This emphasis on “Quality by
Design” is making it increasingly important for life science
manufacturers to invest early in the product life cycle
during process development and to build a sound basis for a
“control space”. This session provides an update on FDA
regulations related to PAT and QbD and also discusses
considerations for Design Space development in QbD.
• Update on FDA practices and expectations for PAT
and QbD
• Control strategy and use of in-process and final
product testing
4
Panel
Discussion
photo by: Photolink / Getty Images
• Identifying challenges including:
* defining Design Space
* identifying critical process parameters
* integrating control strategy
* reporting requirements for changes within the
Design Space
• Top reasons for drug quality defects
• FDA guidance on the horizon
Richard P. Poska, R.Ph., Director, Global Pharmaceutical Regulatory Affairs,
CMC-GPRD Small Molecule Support, Abbott
3:00 Networking and Refreshment Break
3:30 Emerging Manufacturing Control Systems for
Improved Operational Performance
This session illustrates how MCS (Manufacturing
Control Systems) can achieve seamless and
synchronized system architecture to support electronic
batch records and exception reporting for automation
and production management.
• What is an MCS (Manufacturing Control System)
• Benefits of an integrated system
• Challenges of MES and batch automation
• Standards and technology — Current practice
• Vision for future systems
Carey Clements, Life Sciences MES Product Manager, Honeywell
4:15 Industry Directions for MES Adoption,
Integration and Standards
This panel discussion convenes industry MES leaders
and trailblazers to discuss the state of MES adoption,
challenges in achieving integration and the future of
standards adoption.
• Views on the level of MES sophistication to date
• New enhancements and advancements in systems
and processes
• Most problematic challenges in achieving MES
interoperability and enterprise-wide integration
• Outlook for standards adoption and the need for
further standardization
Moderator: Tony Fenn, Principal Engineer, Bristol-Myers Squibb
Panelists: Paul Brandenburg, Team Lead, Site Execution Systems, Eli Lilly & Co
Michael Asher, Control Engineer, GlaxoSmithKline
Keith T. Evans, Biotech OpU MES Focal Point, TO&PS BSP,
Wyeth Pharmaceuticals
Cathal Strain, Senior Director and Team Leader, API Automation,
Pfizer Inc
5:15 Close of Day One
5:15-6:15 Networking,
Wine & Cheese Reception
Join colleagues and friends in a relaxed setting.

Day Two — Wednesday, August 6, 2008
7:30 Continental Breakfast
8:00 Chairman’s Review of Day One
Dan Matlis, President, Axendia
MES Implementation Strategy and
Lean/MES Case Studies
8:15 How Device, Diagnostic and Biotech
Manufacturers Are Improving Performance with
Real-Time, Predictive and Actionable Intelligence
In the face of increasing competition, frequent new product
introductions and high customer expectations, medical
device, diagnostic and biotech manufacturers are turning
to Manufacturing Execution Systems to help with data
acquisition and process enforcement. Leveraging the data,
manufacturers are advancing to the next level of quality
and performance. This panel convenes industry
professionals to discuss how they use real-time, predictive
and actionable manufacturing intelligence to improve
quality, address issues at the source and accelerate new
product introductions.
Moderator: Dan Matlis, President, Axendia
Panelists: John Oakley, Chief Architect, Manufacturing Systems,
Applied Biosystems
Karim Lokas, Vice President of Product Strategy,
Camstar
Rey Medina, Director of Manufacturing Systems,
Johnson & Johnson Cordis
Gilad Langer, Senior Product Manager,
Camstar
Marc White, MES Program Director,
Boston Scientific (Invited)
Panel
Discussion
9:00 Laying the MES Groundwork through
ISA 88 Process Mapping and Batch Record
Standardization — Shire's Story
Prior to putting the first foot in the “MES waters”, it is
critical that life science organizations plan and execute the
necessary pre-MES groundwork. Ultimate MES success and
measurable results depend upon the early establishment of a
strong MES foundation. This session discusses the steps
taken at Shire to establish a good foundation for an MES
project, scheduled to kick-off in mid-2008. Learn how Shire
walked through the planning, process mapping and
standardization necessary for MES success.
• ISA 88 Mapping —
How ISA 88 mapping probed through four levels
Case
Study
• Leveraging ISA 88 process mapping to
generalize maps configurable for any future products
• Batch Record Standardization — How batch records
were first standardized on paper before going electronic
Samantha Krebs, Senior Process Improvement Technical Writer,
Shire Pharmaceuticals, Inc.
9:40 Advancing from a Home-Grown Legacy
System for Traceability of Device
History Records — Key Considerations,
Objectives and Next Steps
This case study shares the background, business objectives
and considerations taken in mapping out the plan for
advancing Guidant’s home-grown legacy system to a
full-featured MES. As with any medical device organization,
traceability of device history records is paramount.
Medical device manufacturers also need automated and
cost-effective solutions with capabilities to address
regulatory requirements, complex manufacturing needs
and optimized throughput and quality. In this session,
learn the considerations and decision-making steps taken
within Boston Scientific to adapt and advance their
manufacturing organization.
• Home-grown solution for traceability of
Device History Records
• Operational improvements made and underway
• Assessing the current state of the legacy system and
manufacturing quality systems
Case
Study
• Facing the build or buy decision —
Key considerations
• Steps needed to advance from an antiquated
traceability system to a full-functioning MES
• Conducting the “to-be” analysis and examining
next steps
• Lessons learned
Tom Litterer, Manager, Boston Scientific
Tracy McMorrow, Manager, Boston Scientific
10:20 Networking and Refreshment Break
10:50 Embarking on a Pilot and Phased Roll-Out
MES Approach at Bayer's Berkeley Site —
How MES is Taking Form within
Various Production Suites
Bayer Healthcare's Berkeley site is a biotech
facility embarking on an exciting MES roll-out.
This case study discusses the key steps undertaken in
planning for MES implementation, the approach for
MES implementation and the experience to date within
the various production sites using MES.
• Review of Bayer healthcare’s global approach
and the unique approach taken within the
Berkeley facility
• Considerations in choosing an MES supplier
Case
Study
• The pilot approach —
How this works as a phased roll-out for MES
• Experiences to date and lessons learned
Andreas Dankelmann, Project Manager, Organization and Information,
Bayer HealthCare
Case Study Photos by: Getty Images
To Register Call Toll Free 800-817-8601 (781-939-2438 outside the U.S.)
or Fax 781-939-2490. Register on our website at www.cbinet.com
5

6
11:30 Case Study Update — Implementing a Highly
Integrated MES and the Results to Date at BMS’
Devens Biopharmaceutical Manufacturing Facility
Bristol-Myers Squibb is investing $750 million in the
construction of a Large-Scale Cell Culture (LSCC)
manufacturing facility in Devens , MA , for the
commercial production of biopharmaceuticals. The BMS
vision is to implement a fully automated, paperless
solution that supports release by exception utilizing
S95/S88 integrated recipes. This is to be executed using
an MES to orchestrate plant floor automation, lab activity
and materials management. This case study provides an
update on the project thus far and shares key results and
lessons learned to date.
• Recap on the architecture and design of BMS'
Manufacturing Operational Philosophy, with an
emphasis on the MES
• Interface Design — The what and how of working
with SAP, LIMS and Maximo
• Recipe Design, equipment versus process functions
Case
Study
and “reusable recipe patterns”
• Project Methodology — Proof through use, rapid
programming approach, preliminary build versus
final build, teams and skill sets
Tony Fenn, Senior Principal Engineer, Bristol-Myers Squibb
12:10 Elevating Manufacturing Sophistication —
How Schering-Plough and Organon
Leveraged Combined Strengths and MES
for Added Business Value
This case study illustrates some of the key business
drivers for why Schering Plough and Organon turned to
MES for process automation. Learn how these two
manufacturing organizations joined forces, leveraging
shared strengths and talent pool and realized measurable
business value through MES and process automation.
Also hear about some of the chief challenges and lessons
learned along the way.
• Assessing the key business drivers and goals
• Finding ways to extend the business benefit of MES
to get more value and automation out of processes
• Repositioning personnel away from manual tasks and
into roles of higher sophistication and value
Case
Study
• Understanding the technology —
How it is configured and why
• Feeding new functionality into established
MES applications
• Deploying a system and effectively working with the
primary contractor — Lessons learned along the way
David Gerhart, Manager, Computer System,
Validation & Automation Integration, Global Technical Services,
Schering Plough Corporation
Lou Verhagen, Associate Director, Manufacturing,
Organon
12:50 Luncheon
Integration and Interoperability with
Plant-Level and Mobile Systems
2:00 Implementing a Highly-Integrated MES
within a Large-Scale Biotechnology –
Genentech’s Four Year Project
This case history reviews the implementation of a highlyintegrated
MES into a large scale biotech manufacturing
facility. This four year project resulted in the
implementation of an MES as an integral part of a total
Manufacturing Control System. This MES is integrated as
well with several other Site and Corporate Level 3 and 4
Systems to deliver ERP, QC results, electronicallypresented
Procedures, and automatic batch review and
closure to this new paperless manufacturing facility.
Learn the challenges and opportunities, from the MES
perspective, through each phase of this project.
• Project requirements definition
• Software development
• Testing
• Plant commissioning
• Integration strategies
Jeanette Motzer, Manager, Business Applications, Genentech
2:40 Incorporating Wireless MES in a
Biopharmaceutical Facility
Traditional Manufacturing Execution Systems (MES) place
terminals where the work happens, but what if the work
moves? What if your equipment, materials and personnel
operate in a dynamic environment that is constantly
shifting to meet changing demands? That was exactly the
challenge faced by Merck & Company at one of their
biopharmaceutical pilot facilities. This case study
illustrates how Merck met this challenge by embarking on
a program to “cut the cord” and implement critical
functions on wireless handheld devices, which included the
design, development and implementation of wireless
applications while integrating with the existing MES
infrastructure. Participants learn:
• How Merck evaluated and implemented
wireless technologies
• Review of specific issues, such as:
* technology selection
* mapping business needs to the solution
Case * integrating with legacy MES applications
Study
* addressing security concerns
• Strategies learned while developing an open platform
to promote scalability with future systems
Mark Tomcavage, Serac Solutions, LLC
Andrew Kennedy, Research Biochemical Engineer,
Bioprocess Clinical Manufacturing and Technology, Merck & Co
3:20 Close of Conference

WHO SHOULD ATTEND:
You will benefit from attending this event if you are an
executive or senior level director from a pharmaceutical,
biotech or medical device manufacturer with responsibilities
or involvement in the following areas:
• MES • ERP
• Plant/Manufacturing Systems • Manufacturing
• Industrial/Plant Operations • Pharmaceutical Production
• Production Planning • IT
• Process Design • Engineering
• QA/QC • Validation
• Automation • Regulatory
• Continuous Improvement • Process Excellence
This conference will also benefit consultants, technology vendors
and companies providing services to the above delegation.
ACCLAIM FROM PREVIOUS ATTENDEES:
“I benefited enormously. The contents were unique.”
— Ed Harmon, Associate Director of
Manufacturing and Facilities, Biopure
“Very unique conference for all that are thinking
about starting/deploying MES systems.”
— Nirav Shah, Engineer, Schering-Plough
“Good blend of vendor/product information
and real customer experiences.”
— Jerry Cline, IT Manager, GBSC
“Comprehensive overview of the state of MES
in the industry.”
— Ute Bramann, IT Manager,
International Operations, Abbott
“Great opportunity for networking with
industry MES leaders.”
— David Henry, Principle Project Manager,
Wyeth Biotech
“This is an informative, educational sharing of views
and experiences on MES.”
— Dwaraka Ravulapati, IM Lead Analyst, GBSC
Photo by: Jacobs Stock Photography / Getty Images
IN RECOGNITION OF OUR SPONSORS:
CBI Research, Inc’s corporate sponsors represent select companies that share a
common mission: business advancement through thought leadership, strategic
interaction and innovation. The companies represented below are proud contributors
on this program and have carefully selected messaging, branding or positioning
statements to encourage the evaluation and investigation of quality products and/or
services available. We applaud these companies, as well as others that wish to join
the conference, as important members of this event’s delegation.
P l a t i n u m S p o n s o r :
Camstar’s Enterprise Manufacturing
Execution,Quality and Intelligence platform
enables “Closed-Loop Quality Execution,”
the end-to-end business process that
surrounds manufacturing and quality operations. Camstar’s unparalleled solution
optimizes the innovation and risk equation by monitoring and controlling global
manufacturing and quality, and by delivering process interoperability and best practices.
The result is shorter time to market and time to volume, the highest quality products
and leaner, more efficient operations.
Designed for ultimate configurability and built on a services-oriented architecture,
Camstar’s comprehensive solution set includes industry-specific, out-of-the box
applications and a proven implementation methodology ensure successful deployment and
rapid time to benefit. More than 100 leading companies, including Johnson & Johnson,
Roche, Covidien, 3M, Gambro, ZOLL, CIBA Vision, Zeiss, Kinetic Concepts, BIOTRONIK,
Favrille, Stirling Medical Innovations, IBM, Kodak, Philips and Hitachi rely on
Camstar as a trusted software partner.
S t r a t e g i c C o r p o r a t e S p o n s o r :
Emerson Process Management, a business of Emerson
(NYSE: EMR) is the leading process automation technology and
services provider in the world. With annual revenues in
excess of $4B USD in process automation, Emerson enables
API and biotechnology manufacturers to optimize operational
performance, reduce compliance and validation efforts,
shorten cycle and product release times.
TECHNOLOGIES: Integrated through its award winning PlantWeb digital architecture, Emerson provides
manufacturers the most comprehensive and flexible suite of technologies in process automation. Ranging
from hardware that monitors and senses process variables, to control and asset management software, to
advanced process control and batch automation, to compliance and management execution systems…
Emerson fully integrates data across the enterprise to ensure better control, better data management and
easier validation. No automation provider can touch as much of your plant with predictive intelligence and
help you extract the most value from your investments.
SERVICES: Emerson provides the domain expertise of it’s Life Sciences Industry Center to support
customers with project planning, design, engineering and execution, as well as optimization services for
existing facilities to analyze and diagnose operational problems that rob efficiency and profitability and
provide corrective guidance to bring the facility back to optimal performance. Accessible around the world,
Emerson’s Solutions staff integrates with customer personal to collaboratively plan and execute the
programs that bring immediate results while setting a platform for long-term, sustainable performance.
Emerson combines it’s technology and services offering into a unique program for Life Sciences
manufacturers, called the OpX Advantage Program. This proven methodology offers an unparalleled way
to leverage the investments you’ve already made plus integrating state-of-the-art, proven automation tools
to deliver world-class operations.
To learn how Emerson delivers smarter projects and smarter operations, visit
www.emersonprocess.com/lifesciences.
A d d i t i o n a l S p o n s o r s :
If you are interested in sponsorship or exhibit opportunities,
please call Karen Hanover at 781-939-2484, fax 781-939-2536
or email k.hanover@cbinet.com
7

Register by May 30, 2008 and Receive $300 Off Your Registration Fee!
3rd Annual
Manufacturing
Execution Systems
in the Life Sciences Industry
Maximize MES Capabilities within a Lean Organization
and Achieve Enterprise-Wide Integration for
Quality and Performance
AUGUST 5-6, 2008 • THE WESTIN HOTEL • P H I L A D E L P H I A , PA
CD-Rom Compendiums
If you are unable to attend the conference or
you would like extra copies for your colleagues,
you can order your conference CD-Rom today.
Don't miss out on the valuable information
presented by industry leaders exclusively at this
event. The CD-Rom is available for only $198 and
includes the conference agenda, presentations and
speaker biographies. Simply fill out the order form
and the CD-Rom will be shipped to you
2 weeks after the conference occurs. photo by: Keith Brofsky / Getty Images
• Registration Fee: Standard Early Bird
MES AND LIMS —
ALL-INCLUSIVE 3-DAY PASS * $2,795 $2,395
Conference & Workshop
Conference only
Workshop only
* See page 3 for details.
$1,995
$1,595
$895
$1,695
$1,295
$895
Early Bird Discount — Register by May 30, 2008 and SAVE $300.
Fee includes continental breakfast, lunch, wine and cheese reception, refreshments
and CD-Rom Compendium. Please make checks (in U.S. funds drawn on a U.S. bank)
payable to CBI Research, Inc. (No personal checks accepted)
• Team Discount:
Your organization may send 1 executive FREE for every 3 delegates registered.
All registrations must be made at the same time to qualify.
• Discount Accommodations & Travel:
Contact CBI’s official travel service Travel Concepts for all of your travel needs.
In order to receive CBI’s special discounted hotel rate, you must call
Travel Concepts at 800-640-8082 (508-879-8600 outside the U.S.) or
email chris@travelconcept.com by July 11, 2008. Travel Concepts
can also negotiate low group airfares and car rentals. Mention that you are attending
CBI’s 3rd Annual Manufacturing Execution Systems in the Life Sciences Industry
to qualify for hotel and travel discounts. All travel arrangements subject to availability.
• Venue:
The Westin Hotel
99 South 17th Street • Philadelphia, PA 19103
Negotiated rates only available through Travel Concepts
• Substitution & Cancellation:
Your registration may be transferred to a member of your organization up to
5 EASY WAYS
TO REGISTER
WEBSITE
www.cbinet.com
Best
Value
CALL TRAVEL CONCEPTS
TODAY AT 800-640-8082
24 hours in advance of the conference. Cancellations received in writing on or before
July 22, 2008 will be refunded, less a $195 administrative charge. No refunds
will be made after this date; however, the registration fee less the $195 administrative
charge can be credited to another CBI conference if you register within 6 months from
the date of this conference. In case of conference cancellation,
CBI’s liability is limited to refund of the conference registration fee only.
CBI reserves the right to alter this program without prior notice.
Please Note: Speakers and agenda are subject to change without notice.
In the event of a speaker cancellation, every effort to find a suitable replacement will
be made. The opinions of the conference faculty do not necessarily reflect those of the
companies they represent or The Center for Business Intelligence.
• Satisfaction Guaranteed:
CBI stands behind the quality of its conferences. If you are not satisfied with the
quality of the conference, a credit will be awarded towards a comparable
CBI conference of your choice.
CBI Research, Inc.
500 West Cummings Park, Suite 5100, Woburn, MA 01801
Registration Card DO NOT REMOVE MAILING LABEL. PLEASE RETURN ENTIRE FORM. PC08044
Yes! Please register me for CBI’s 3rd Annual Manufacturing Execution Systems in the Life Sciences Industry.
Conference & Workshop A Conference & Workshop B Conference only Workshop A only Workshop B only
Yes! Please register me for CBI’s 3rd Annual Manufacturing Execution Systems in the Life Sciences
Industry AND Enterprise LIMS for the Bio/Pharma Industry all-inclusive 3 day pass.
I am registering for the EARLY BIRD DISCOUNT We would like to take advantage of the TEAM DISCOUNT (see left for details).
I cannot attend. Please send me a Conference CD-Rom Compendium.
Do you have any special needs?________________________________________________
Register 3
PRIORITY CODE (appears below mailing address): ______________________________
Get 1 FREE
1. NAME POSITION
2. NAME POSITION
3. NAME POSITION
4. NAME POSITION
COMPANY DIVISION
ADDRESS
CITY STATE/COUNTRY ZIP/POSTAL CODE
TELEPHONE FAX E-MAIL
AUTHORIZED SIGNATURE
PRSRT STD
U.S. Postage
PAID
Gallery
FREE
Payment Options: Payment in full is required to process registration. Please call with any payment questions.
Enclosed is a check for payment in full (No personal checks accepted)
MC/Visa:
Amex:
PHONE
800-817-8601
781-939-2438
outside the U.S.
NAME (AS APPEARS ON CARD) EXP. DATE
CARDHOLDER SIGNATURE
FAX
781-939-2490
DON’T MISS THE CONFERENCE THAT CONVENED
OVER 200 EXECUTIVES IN 2007!!
Featuring Speakers From:
Abbott • Applied Biosystems
Bayer HealthCare • Boston Scientific
Bristol-Myers Squibb
Cordis, a Johnson & Johnson Company
Eli Lilly & Co • Genentech
GlaxoSmithKline • Merck & Co • Organon
Pfizer Inc • Schering Plough Corp
Shire Pharmaceuticals, Inc.
Wyeth Pharmaceuticals
E-MAIL
cbireg@cbinet.com
Please include all information
requested on registration card.
Save $400 by Registering for
both the MES AND LIMS
Please
photocopy this
form for
additional
delegates.
MAIL
Registration Dept.
CBI Research, Inc.
500 West Cummings Park,
Suite 5100, Woburn, MA 01801